Perforated peptic ulcer: Use of pre-admission oral glucocorticoids and 30-day mortality

Alimentary Pharmacology and Therapeutics

Volumn 23, Issue 1, 2006, Pages 45-52

  Christensen, S ^a   Riis, A ^a   Norgaard M ^a   Thomsen, R W ^a   Tonnesen E M ^a   Larsson, A ^b   Sorensen H T ^a,c  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AALBORG UNIVERSITY HOSPITAL   (Denmark)

^c BOSTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIULCER AGENT; GLUCOCORTICOID; HISTAMINE H2 RECEPTOR ANTAGONIST; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; COMORBIDITY; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA BASE; DENMARK; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MORTALITY; POPULATION RESEARCH; PRESCRIPTION; PRIORITY JOURNAL; REGISTER; ULCER PERFORATION;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; DENMARK; FEMALE; GLUCOCORTICOIDS; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PEPTIC ULCER PERFORATION; STOMACH ULCER; TIME FACTORS;

EID: 33644895466     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2006.02722.x     Document Type: Article

References (29)

1. Walsh LJ Wong CA Pringle M et al. Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: a cross sectional study BMJ 1996 313 344 6
2. Nielsen GL Sørensen HT Mellemkjær L et al. Risk of hospitalization resulting from upper gastrointestinal bleeding among patients taking corticosteroids: a register-based cohort study Am J Med 2001 111 541 5
3. Green SB Gail MH Steroids and peptic ulcer N Engl J Med 1976 294 473 6
4. Messer J Reitman D Sacks HS et al. Association of adrenocorticosteroid therapy and peptic ulcer disease N Engl J Med 1983 309 21 24
5. Hernandez-Diaz S Garcia-Rodriguez LA Incidence of serious upper gastrointestinal bleeding/perforation in the general population: Review of the epidemiologic studies J Clin Epidemiol 2002 55 157 63
6. Svanes C Trends in perforated peptic ulcer: incidens, etiology, treatment, and prognosis World J Surg 2000 24 277 83
7. Testini M Portincasa P Piccini G et al. Significant factors associated with fatal outcome in emergency open surgery for perforated peptic ulcer World J Gastroenterology 2003 9 2338 40
8. Irvin TT Mortality and perforated peptic ulcer: a case for risk stratification in elderly patients Br J Surg 1989 76 215 8
9. Boey J Choi SHY Alagaratnam TT et al. Risk stratification in perforated duodenal ulcers. A prospective validation of predictive factors Ann Surg 1987 205 22 6
10. Bodner B Harrington Me Kim U A multifactorial analysis of mortality and morbidity in perforated peptic ulcer disease Surg Gynecol Obstet 1990 171 315 20
11. Noguiera C Silva AS Santos JN et al. Perforated peptic ulcer: main factors of morbidity and mortality World J Surg 2003 27 782 7
12. Wakayama T Ishizaki Y Mitsusada M et al. Risk factors influencing the short-term results of gastroduodenal perforation Surg Today 1994 24 681 7
13. Hamby L Zweng T Strodel W Perforated gastric and duodunal ulcer Am Surg 1993 59 319 23
14. Bulut O Rasmussen C Fischer A Acute surgical treatment of complicated peptic ulcer with special reference to the elderly World J Surg 1996 20 574 7
15. McIntosh JH Berman K Hooliday FM et al. Some factors associated with mortality in perforated peptic ulcer: a case-control study J Gastroenterol Hepatol 1996 11 93 96
16. Henry AD Johnston A Dobson A et al. Fatal peptic ulcer complications and the use of non-steroidal anti-inflammatory drugs, aspirin, and corticosteroids BMJ 1987 295 1227 9
17. Dayton MT Kleckner SC Brown DK Peptic ulcer perforation associated with steroid use Arch Surg 1987 122 376 80
18. Evans JP Smith R Predicting poor outcome in perforated peptic ulcer disease Aust N Z J Surg 1997 67 792 5
19. Andersen TF Madsen M Jørgensen J et al. The Danish National Hospital Register. A valuable source of data for modern health sciences Dan Med Bull 1999 46 263 8
20. Gaist D Sørensen HT Hallas J The Danish prescription registries Dan Med Bull 1997 44 445 8
21. Charlson ME Pompei P Ales KL et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation J Chronic Dis 1987 40 373 83
22. de Groot V Beckerman H Lankhorst GJ et al. How to measure comorbidity. A critical review of available methods J Clin Epidemiol 2003 56 221 9
23. Deyo RA Cherkin DC Ciol MA Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases J Clin Epidemiol 1992 45 613 9
24. Cattaruzzi C Troncon MG Agostinis L et al. Positive predictive value of ICD 9th codes for upper gastrointestinal bleeding and perforation in the Sistema Informativo Sanitario Regionale Database J Clin Epidemiol 1999 52 499 502
25. Nickelsen TN Data validity and coverage in the Danish National Health Register Ugeskr Laeger 2002 164 33 7
26. Mellemkjær L Blot WJ Sørensen HT et al. Upper gastrointestinal bleeding among users of NSAIDs: a population-based cohort study in Denmark Br J Clin Pharmacol 2002 53 173 81
27. Collier D Pain JA Non-steroidal anti-inflammatory drugs and peptic ulcer perforation Gut 1985 26 359 63
28. Canoy DS Hart AR Todd CJ Epidemiology of duodenal ulcer perforation: a study on hospital admissions in Norfolk, United Kingdom Dig Liver Dis 2002 34 322 7
29. Sillakivi T Lang A Tein A et al. Evaluation of risk factors for mortality in surgically treated perforated peptic ulcer Hepatogastroenterology 2000 47 1765 8